Where is Cellerix headquartered?

Cellerix is located in Madrid, Madrid.

Who invested in Cellerix?

Cellerix has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Cellerix?

Cellerix closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

cellerix.com

Cellerix

Cellerix is a biotechnology company developing therapies based on adult stem cells.

Business Model:

Revenue: $10M

Employees: 2-10

Rankings

Industries / Tags:

Biotechnology

Medical

Pharmaceutical

Detailed Cellerix Information

M&A Details

Cellerix was acquired by TiGenix.
The acquisition happend on 2011-02-25.
Details of the transaction were not public

Acquirer

TiGenix

General Information

Geographic Data

Address:

City: Madrid

State: Madrid

Zip:

Country: Spain

Financial Info

Stage:

series c

Raised Last:

$38M

Raised Total:

$115M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Cellerix, S.A., a biotechnology company, engages in the development and production of medicines based on the use of stem cells of adult origin. The company offers products for the treatment of gastroenterology, dermatology, and immune-based diseases. Its products include Cx401, which is used for the treatment of complex perianal fistulas; and Cx501, a cell therapy product to be applied in the treatment of Epidermolysis Bullosa. Cellerix, S.A. was founded in 2004 and is based in Tres Cantos, Spain.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2010	Series C	6	$37.7M	EQT life science Grupo Genetrix Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital EQT life science Grupo Genetrix Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital
11/2009	Series B	6	$40.5M	Biopartners Capital EQT life science Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital Biopartners Capital EQT life science Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital
9/2007	Series B	5	$37.2M	EQT life science Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital EQT life science Novartis Venture Fund Roche Venture Fund Ventech Ysios Capital

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details